Skip to main content
. Author manuscript; available in PMC: 2023 Feb 18.
Published in final edited form as: Circ Res. 2022 Feb 17;130(4):652–672. doi: 10.1161/CIRCRESAHA.121.319895

Table 3.

Unanswered questions and key areas for future research on sex-specific cardiovascular disease risk factors in women.

Menarche and fertility
 ● Do unique hormonal or epigenetic mechanisms link early and late menarche and polycystic ovary syndrome with future CVD risk?
 ● Are assisted reproductive technologies causally linked to CVD or simply a signal for underlying infertility and associated shared risk factors with CVD?
Pregnancy and adverse pregnancy outcomes
 ● What are the shared and unique pathophysiologic pathways underlying the various adverse pregnancy outcomes? How do long-term cardiometabolic implications differ across different adverse pregnancy outcomes and their subtypes?
 ● What are the key novel mechanisms and pathways linking adverse pregnancy outcomes with later-life CVD risk?
 ● Are associations between parity and CVD risk driven by socio-behavioral or biological effects (or both)?
 ● What is the protective mechanism of breastfeeding against CVD, and can this be leveraged therapeutically?
Menopause
 ● Do cardiometabolic changes during the menopause transition independently predict future CVD?
 ● What are the mechanisms linking premature age of menopause and vasomotor symptoms with CVD?
 ● What are the relationships among clonal hematopoiesis of indeterminate potential, premature menopause, and CVD?
 ● Is there a role for exogenous estradiol in cardiometabolic and lipid profile improvement in subsets of postmenopausal women?
Overarching questions for future research
 ● Can reproductive history prompt targeted cardiometabolic risk-reduction approaches for primordial and primary prevention?
 ● Can mechanistic insights into reproductive exposures yield novel preventive strategies and therapeutics?
 ● How do associations between reproductive history and CVD differ across racial/ethnic groups?
 ● Can sex-specific cardiovascular risk prediction models effectively incorporate reproductive history to refine risk prediction?
 ● How can we better educate clinicians about the role of reproductive history in CVD risk?

CVD = cardiovascular disease